Riskpilot← Back to searchSign inGet full accessVårdmark AB
ABActiveOrg 5591611842Sysslomansgatan 18 Lgh 1201Medical specialists activities · NACE 8622Est. 20181 employees
Revenue 2025
SEK 174K
-11% vs 2024
EBITDA margin
31.0%
-50% vs 2024
Equity ratio
89.4%
Financial strength
Net profit 2025
SEK 39K
-48% vs 2024
| Revenue | SEK 174K | -11% |
| EBITDA | SEK 54K | -50% |
| Net profit | SEK 39K | -48% |
| Total assets | SEK 186K | -16% |
| Equity | SEK 167K | -20% |
| Employees | 1 | — |
Legal name
Vårdmark AB
Org number
5591611842
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
1 juni 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Verksamheten innefattar arbete inom sjukvård med urologi som fokus samt konsultarbete inom läkemedelsbranschen.
Address
Sysslomansgatan 18 Lgh 1201
Email
truls.g@me.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 297 | 223 | 191 | 196 | 174 |
| Staff expenses | — | −16 | −16 | −0 | −18 |
| EBITDA | 196 | 120 | 100 | 108 | 54 |
| Depreciation & amort. | −13 | −14 | −15 | −14 | −6 |
| EBIT | 183 | 106 | 85 | 94 | 47 |
| Net financials | — | −0 | 0 | 1 | 2 |
| Profit before tax | 182 | 106 | 85 | 95 | 50 |
| Tax | −39 | −22 | −17 | −19 | −10 |
| Net profit | 143 | 84 | 67 | 75 | 39 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 271 | 219 | 199 | 221 | 186 |
| Equity | 230 | 215 | 182 | 207 | 167 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 40 | 5 | 17 | 14 | 20 |
| Total debt | 40 | 5 | 17 | 14 | 20 |
EBITDA margin
31.0%
This company
15.8%
Market median
+96% vs market
20212025
Equity ratio
89.4%
This company
38.2%
Market median
+134% vs market
20212025
Return on equity
23.6%
This company
18.4%
Market median
+28% vs market
20212025
Net profit margin
22.6%
This company
8.1%
Market median
+179% vs market
20212025
Asset turnover
0.93×
This company
1.12×
Market median
+17% vs market
20212025
Debt / equity
0.12×
This company
0.62×
Market median
+81% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Vårdmark AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bo Henrik Gårdmark | Deputy Board Member | 0 companies |
| Truls Göran Henrik Gårdmark | Chairman | 0 companies |
| Vera Signe Ingrid Gårdmark | Deputy Board Member | 0 companies |
| Marie Christina Gårdmark | Board of Directors | 0 companies |
| Ebba Christina Gårdmark | Deputy Board Member | 0 companies |